(NP (NP (NP Regulation/NN) (PP of/IN (NP interleukin-1/NN beta/NN production/NN)) (PP by/IN (NP glucocorticoids/NNS)) (PP in/IN (NP human/JJ monocytes/NNS)) :/:) (S (NP-SBJ (NP the/DT mechanism/NN) (PP of/IN (NP action/NN))) (VP depends/VBZ (PP on/IN (NP the/DT activation/NN signal/NN))) ./.))
(S (NP-SBJ-1 Glucocorticoids/NNS) (VP are/VBP (VP known/VBN (S (NP-SBJ *-1/-NONE-) (VP to/TO (VP downregulate/VB (NP (NP interleukin-1/NN beta/NN production/NN) (PP in/IN (NP monocytic/JJ cells/NNS))) (PP by/IN (NP (NP two/CD different/JJ mechanims/NNS) :/: (NP-COOD (NP (NP direct/JJ inhibition/NN) (PP of/IN (NP the/DT gene/NN transcription/NN))) and/CC (NP (NP destabilization/NN) (PP of/IN (NP the/DT preformed/JJ interleukin-1/NN beta/NN mRNA/NN))))))))))) ./.)
(S (ADVP-TMP Now/RB) (NP-SBJ we/PRP) (VP have/VBP (VP examined/VBN (NP (NP the/DT effect/NN) (PP of/IN (NP (NP the/DT nature/NN) (PP of/IN (NP the/DT monocyte/NN activating/NN signal/NN)))) (PP on/IN (NP these/DT two/CD inhibitory/JJ mechanims/NNS))))) ./.)
(S (SBAR-TMP (WHADVP-100 When/WRB) (S (NP-SBJ-10 human/JJ monocytes/NNS) (VP were/VBD (VP-COOD (VP preincubated/VBN (NP *-10/-NONE-) (PP with/IN (NP dexamethasone/NN)) (PP-TMP for/IN (NP 1/CD hour/NN)) (ADVP *T*-100/-NONE-)) and/CC then/RB (VP stimulated/VBN (NP *-10/-NONE-) (PP either/CC with/IN (NP-COOD (NP bacterial/JJ lipopolysaccharide/NN) or/CC (NP phorbol/NN myristate/NN))) (ADVP *T*-100/-NONE-)))))) ,/, (NP-SBJ it/PRP) (VP was/VBD (VP found/VBN (SBAR that/IN (S-COOD (S (NP-SBJ dexamethasone/NN) (VP inhibited/VBD (NP the/DT lipopolysaccharide-induced/JJ interleukin-1/NN beta/NN protein/NN production/NN))) ,/, but/CC (S (NP-SBJ-3 the/DT (ADJP phorbol/NN myristate-induced/JJ) production/NN) (VP was/VBD (VP increased/VBN (NP *-3/-NONE-) (NP (QP 3-10/CD) fold/RB)))))))) ./.)
(S (NP-SBJ-2 This/DT difference/NN) (VP was/VBD (ADVP also/RB) (VP seen/VBN (NP *-2/-NONE-) (PP at/IN (NP the/DT mRNA/NN level/NN)))) ./.)
(S (SBAR-TMP (WHADVP-101 When/WRB) (S (NP-SBJ-4 dexamethasone/NN) (VP was/VBD (VP added/VBN (NP *-4/-NONE-) (PP to/TO (NP the/DT cultures/NNS)) (PP-TMP (NP 3/CD hours/NNS) after/IN (NP the/DT stimulators/NNS)) (ADVP *T*-101/-NONE-))))) ,/, (NP-SBJ it/PRP) (ADVP clearly/RB) (VP decreased/VBD (NP the/DT interleukin-1/NN beta/NN mRNA/NN levels/NNS) (ADVP regardless/RB (PP of/IN (NP (NP the/DT stimulator/NN) (VP used/VBN (NP */-NONE-))))) -LRB-/-LRB- (SBAR although/IN (S (NP-SBJ the/DT effect/NN) (VP was/VBD (ADJP-PRD clearly/RB weaker/JJR) (PP on/IN (NP the/DT PMA-induced/JJ mRNA/NN))))) -RRB-/-RRB-) ./.)
(S (ADVP Thus/RB) (NP-SBJ these/DT data/NNS) (VP suggest/VBP (SBAR that/IN (S-COOD (S (NP-SBJ-5 (NP the/DT (ADJP phorbol/NN myristate-induced/JJ) signal/NN) (PRN -LRB-/-LRB- (FRAG (NP prolonged/JJ protein/NN kinase/NN C/NN activation/NN) ?/.) -RRB-/-RRB-)) (VP can/MD not/RB (VP be/VB (VP inhibited/VBN (NP *-5/-NONE-) (PP by/IN (NP-LGS (NP prior/JJ incubation/NN) (PP with/IN (NP dexamethasone/NN)))))))) and/CC (S (NP-SBJ it/PRP) (ADVP also/RB) (VP protects/VBZ (NP the/DT induced/VBN mRNA/NN) (PP for/IN (NP (NP the/DT degradative/JJ action/NN) (PP of/IN (NP dexamethasone/NN))))))))) ./.)
